Gain Therapeutics (GANX) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.42
-0.31
-0.19
-0.08

Details

Expected EPS
-0.179825
Actual EPS
-0.16
Surprise EPS
0.02
Surprise Percent
+11.02%

Description

Gain Therapeutics (GANX) has reported earnings of -0.16 per share for Q2 2025.

0 Comments

Share your thoughts